ESPE Abstracts (2018) 89 P-P3-193

Growth Hormone Deficiency Intwo Children with Williams-Beuren Syndrome: The Long-Term Response to Growth Hormone (GH) Therapy

Ashraf Solimana, Ashraf Adelb & fawzia Alyafieib


aUniversity of Alexandria Children Hospital, Alexandria, Qatar; bHamad Medical Center, Doha, Qatar


Background: Pre- and postnatal growth retardation of unknown pathogenesis is a common clinical feature in patients with Williams-Beuren syndrome (WBS). However, growth hormone deficiency (GHD) has not been considered a major cause of growth retardation.

Case reports: We report two female patients with confirmed WBS who had defective GH secretion in response to two provocative tests and low IGF-I level and their growth response to GH therapy for 9 years. The first patient was investigated at the age of 7 years with HtSDS =−3, BMISDS =0.8 and bone age =7 years, Peak GH response to 2 provocative tests (Clonidine and glucagon) was 6.5 and 5.9 ng/dl respectively, IGFSDS =−2.2. She was started on HGH 0.05 mg/kg daily for 9 years with a significant increase in IGF-I. She attained normal pubertal development and pubertal growth spurt. Her final adult height =155 cm (HtSDS=−2) and weight =52 kg. The second female patient had undergone surgical repair for supra-valvular aortic stenosis at 6 months of age. She was investigated at the age of 5 years because of her HtSDS =−2.8, BMI =10 kg/m2 and IGF-ISDS =−2.7 and bone age =5 years. She underwent two provocative tests which showed subnormal peak GH response (5.6 and 7 ng/dl). She was started on GH 0.05 mg/kg daily with good increment in IGF-I. At the age of 11 years she started her pubertal development and at the age of 12 years her height =135.5 cm (HtSDS =−2) and BMI =12 kg/m2 and her bone age =12 years.

Discussion: The growth pattern of children with WBS is characterized by prenatal growth deficiency, failure to thrive in infancy (70%), poor weight gain and linear growth in the first four years; a rate of linear growth that is 75% of normal in childhood; and a brief pubertal growth spurt. The mean adult height is below the third centile. These two patients with defective GH-IGF-I axis showed a good response to long-term GH therapy with a stature gain =1 S.D. and normal pubertal growth spurt. The pathogenesis of GHD in our patient is unclear.

Conclusion: GH deficiency might contribute to the growth failure in some patients with WBS and in such cases, HGH therapy will most likely improve final height.

Article tools

My recent searches

No recent searches.